152 related articles for article (PubMed ID: 19713605)
41. Characterization of focal hepatic lesions with contrast-enhanced C-cube gray scale ultrasonography.
Wang WP; Ding H; Qi Q; Mao F; Xu ZZ; Kudo M
World J Gastroenterol; 2003 Aug; 9(8):1667-74. PubMed ID: 12918098
[TBL] [Abstract][Full Text] [Related]
42. Differentiation of benign from malignant focal splenic lesions using sulfur hexafluoride-filled microbubble contrast-enhanced pulse-inversion sonography.
Stang A; Keles H; Hentschke S; von Seydewitz CU; Dahlke J; Malzfeldt E; Braumann D
AJR Am J Roentgenol; 2009 Sep; 193(3):709-21. PubMed ID: 19696284
[TBL] [Abstract][Full Text] [Related]
43. Imaging of focal liver lesions: low-mechanical-index real-time ultrasonography with SonoVue.
Ding H; Wang WP; Huang BJ; Wei RX; He NA; Qi Q; Li CL
J Ultrasound Med; 2005 Mar; 24(3):285-97. PubMed ID: 15723841
[TBL] [Abstract][Full Text] [Related]
44. Characterization of focal hepatic lesions in cirrhotic patients by Pulse Inversion Harmonic Imaging US contrast specific technique with Levovist.
Quaia E; Forgács B; Calderan L; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2002 Oct; 104(4):285-94. PubMed ID: 12569309
[TBL] [Abstract][Full Text] [Related]
45. The usefulness of 1.5 harmonic imaging ultrasonography with Levovist in the diagnosis of focal hepatic tumors.
Yamamoto K; Shiraki K; Nakanishi S; Fuke H; Hashimoto A; Shimizu A; Nakano T
Int J Oncol; 2005 Oct; 27(4):989-95. PubMed ID: 16142315
[TBL] [Abstract][Full Text] [Related]
46. An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography.
Wilson SR; Burns PN
AJR Am J Roentgenol; 2006 May; 186(5):1401-12. PubMed ID: 16632737
[TBL] [Abstract][Full Text] [Related]
47. Dynamic sonography of hepatic tumors.
Tanaka S; Ioka T; Oshikawa O; Hamada Y; Yoshioka F
AJR Am J Roentgenol; 2001 Oct; 177(4):799-805. PubMed ID: 11566675
[TBL] [Abstract][Full Text] [Related]
48. Characterization of focal liver lesions with a new ultrasound contrast agent using continuous low acoustic power imaging: comparison with contrast enhanced spiral CT.
Passamonti M; Vercelli A; Azzaretti A; Rodolico G; Calliada F
Radiol Med; 2005 Apr; 109(4):358-69. PubMed ID: 15883520
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of enhancement patterns of focal nodular hyperplasia in contrast-enhanced, wide-band phase-inversion harmonic power Doppler imaging of the liver.
Janica J; Serwatka W; Polaków J; Ustymowicz A; Walecki J; Ladny JR; Dobrzycki S
Med Sci Monit; 2004 Jun; 10 Suppl 3():17-21. PubMed ID: 16538193
[TBL] [Abstract][Full Text] [Related]
50. Real-time contrast-enhanced ultrasound imaging of focal liver lesions in fatty liver.
Liu GJ; Wang W; Xie XY; Xu HX; Xu ZF; Zheng YL; Liang JY; Moriyasu F; Lu MD
Clin Imaging; 2010; 34(3):211-21. PubMed ID: 20416486
[TBL] [Abstract][Full Text] [Related]
51. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].
Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C
Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451
[TBL] [Abstract][Full Text] [Related]
52. Detection and differential diagnosis of hepatic masses using pulse inversion harmonic imaging during the liver-specific late phase of contrast enhancement with Levovist.
Yücel C; Ozdemir H; Gürel S; Ozer S; Araç M
J Clin Ultrasound; 2002 May; 30(4):203-12. PubMed ID: 11981929
[TBL] [Abstract][Full Text] [Related]
53. Benefits of contrast-enhanced sonography for the detection of liver lesions: comparison with histologic findings.
Chami L; Lassau N; Malka D; Ducreux M; Bidault S; Roche A; Elias D
AJR Am J Roentgenol; 2008 Mar; 190(3):683-90. PubMed ID: 18287439
[TBL] [Abstract][Full Text] [Related]
54. Differentiation between malignant and benign nodules in the liver: use of contrast C3-MODE technology.
Luo BM; Wen YL; Yang HY; Zhi H; Ou B; Ma JH; Pan JS; Dai XN
World J Gastroenterol; 2005 Apr; 11(16):2402-7. PubMed ID: 15832408
[TBL] [Abstract][Full Text] [Related]
55. Value of contrast-enhanced power Doppler sonography using a microbubble echo-enhancing agent in evaluation of small breast lesions.
Kook SH; Kwag HJ
J Clin Ultrasound; 2003 Jun; 31(5):227-38. PubMed ID: 12767017
[TBL] [Abstract][Full Text] [Related]
56. Analysis of different contrast enhancement patterns after microbubble-based contrast agent injection in liver hemangiomas with atypical appearance on baseline scan.
Quaia E; Bartolotta TV; Midiri M; Cernic S; Belgrano M; Cova M
Abdom Imaging; 2006; 31(1):59-64. PubMed ID: 16333704
[TBL] [Abstract][Full Text] [Related]
57. Differentiation of focal liver lesions: usefulness of parametric imaging with contrast-enhanced US.
Anaye A; Perrenoud G; Rognin N; Arditi M; Mercier L; Frinking P; Ruffieux C; Peetrons P; Meuli R; Meuwly JY
Radiology; 2011 Oct; 261(1):300-10. PubMed ID: 21746815
[TBL] [Abstract][Full Text] [Related]
58. Contrast-enhanced ultrasound for the diagnosis of hepatic adenoma.
Zhu XL; Chen P; Guo H; Zhang N; Hou WJ; Li XY; Xu Y
J Int Med Res; 2011; 39(3):920-8. PubMed ID: 21819725
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic features of real-time contrast-enhanced ultrasound in focal nodular hyperplasia of the liver.
Piscaglia F; Venturi A; Mancini M; Giangregorio F; Vidili G; Magnolfi F; Mirarchi M; Fornari F; Bolondi L
Ultraschall Med; 2010 Jun; 31(3):276-82. PubMed ID: 19941252
[TBL] [Abstract][Full Text] [Related]
60. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
Grazioli L; Morana G; Kirchin MA; Schneider G
Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
